Your browser doesn't support javascript.
loading
HIV-1 DNA predicts disease progression and post-treatment virological control.
Williams, James P; Hurst, Jacob; Stöhr, Wolfgang; Robinson, Nicola; Brown, Helen; Fisher, Martin; Kinloch, Sabine; Cooper, David; Schechter, Mauro; Tambussi, Giuseppe; Fidler, Sarah; Carrington, Mary; Babiker, Abdel; Weber, Jonathan; Koelsch, Kersten K; Kelleher, Anthony D; Phillips, Rodney E; Frater, John.
Afiliación
  • Williams JP; Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
  • Hurst J; Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
  • Stöhr W; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, United Kingdom.
  • Robinson N; Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
  • Brown H; Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
  • Fisher M; Department of Sexual Health and HIV, Brighton and Sussex University Hospitals, Brighton, United Kingdom.
  • Kinloch S; Division of Infection and Immunity, School for Life Sciences, University College London, London, United Kingdom.
  • Cooper D; The Kirby Institute of New South Wales, Sydney, Australia.
  • Schechter M; Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Tambussi G; Department of Infectious Diseases, Ospedale San Raffaele, Milan, Italy.
  • Fidler S; Division of Medicine, Wright Fleming Institute, Imperial College, London, United Kingdom.
  • Carrington M; Cancer and Inflammation Program, Laboratory of Experimental Immunology, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, United States.
  • Babiker A; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, United Kingdom.
  • Weber J; Division of Medicine, Wright Fleming Institute, Imperial College, London, United Kingdom.
  • Koelsch KK; The Kirby Institute of New South Wales, Sydney, Australia.
  • Kelleher AD; The Kirby Institute of New South Wales, Sydney, Australia.
  • Phillips RE; Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
  • Frater J; Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
Elife ; 3: e03821, 2014 Sep 12.
Article en En | MEDLINE | ID: mdl-25217531
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Viral / Infecciones por VIH / VIH-1 / Progresión de la Enfermedad / Terapia Antirretroviral Altamente Activa Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Elife Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Viral / Infecciones por VIH / VIH-1 / Progresión de la Enfermedad / Terapia Antirretroviral Altamente Activa Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Elife Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido